"The US Food and Drug Administration (FDA) has approved 5-aminolevulinic acid (ALA; Ameluz, Biofrontera) gel in combination with the activating BF-RhodoLED photodynamic therapy (PDT) lamp for treatment of patients with actinic keratosis ("...
Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
DOSAGE AND ADMINISTRATION
Topical corticosteroids are generally applied to the affected area as a thin film from two to three times daily depending on the severity of the condition.
The lotion may be applied topically to the specified lesions, particularly to those in hairy areas, two times per day.The lotion should be rubbed into the affected area completely, and the area should be protected from washing, clothing, rubbing, etc.until the lotion is dried. Occlusive dressings may be a valuable therapeutic adjunct for the management of psoriasis or recalcitrant conditions.
If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
Amcinonide Lotion, 0.1% is supplied as follows:
NDC 0168-0280-60............................60 mL bottle
Store at controlled room temperature 15° - 30°C (59° - 86°F). DO NOT FREEZE.
E.FOUGERA & CO., a division of Altana Inc, MELVILLE, NEW YORK 11747. Rev 08/02. FDA Rev date: 11/6/2002This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 9/15/2008
Additional Amcinonide Lotion Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.